[HTML][HTML] Evaluasi tingkat akurasi penggunaan metode deep learning dengan algoritma convolutional neural network pada citra dermatoskopi untuk efisiensi diagnosis …

RAS Lubis - Holistik Jurnal Kesehatan, 2024 - ejurnal.malahayati.ac.id
Background: Cutaneous melanoma (KM) is a malignant cancer on the surface of the skin
that requires immediate diagnosis. Deep learning methods using artificial intelligence with …

以低溫壓印技術製備咪喹莫特微針應用於皮膚黑色素瘤之治療

林照祺 - 中原大學生物醫學工程學系學位論文, 2023 - airitilibrary.com
黑色素瘤是一種嚴重的皮膚癌, 目前臨床尚未出現對早期患者有效的輔助治療方法.
咪喹莫特乳膏是目前廣泛應用於皮膚疾病治療的藥物, 由於皮膚角質層的存在限制了藥物的滲透 …

牛樟芝菌絲體成分Antrodin B 對黑色素瘤轉移作用之探討

李承煬 - 中山醫學大學健康產業科技管理學系學位論文, 2023 - airitilibrary.com
黑色素瘤(Melanoma) 為致死率最高的皮膚癌之一, 具有高度轉移(Metastasis) 的能力,
而癌症轉移常常是造成癌症病患死亡的主因, 且發生癌症轉移的患者其通常預後不良 …

A Review for Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors

SO Renato Filho, DA Oliveira, MM Nisimoto, LC Marti - 2023 - preprints.org
Advanced cutaneous melanoma is considered the most aggressive type of skin cancer with
variable rates of treatment response. Nowadays, there are available some classes of …

[HTML][HTML] ЛЕКАРСТВЕННАЯ ТЕРАПИЯ МЕЛАНОМЫ КОЖИ: СОВРЕМЕННОЕ СОСТОЯНИЕ И ПЕРСПЕКТИВЫ (ОБЗОР ЛИТЕРАТУРЫ)

АЗ Гусейнов, ВИ Федорищев - Вестник новых медицинских …, 2023 - cyberleninka.ru
Работа посвящена вопросам лекарственного лечения меланомы кожи. Современное
лекарственное лечение меланомы кожи включает иммунную, таргетную и, в меньшей …

[HTML][HTML] Di-arginine and FFAT-like motifs retain a subpopulation of PRA1 at ER-mitochondria membrane contact sites

A Abu Irqeba, JM Ogilvie - Plos one, 2020 - journals.plos.org
Prenylated Rab Acceptor 1 (PRA1/Rabac1) is a four-pass transmembrane protein that has
been found to localize to the Golgi and promiscuously associate with a diverse array of Rab …

Investigating Therapeutic Efficacy of Dacarbazine and Temozolomide, Alone and in Combination with BRAF (V600E) siRNA in A375 Human Melanoma Cell Line

F Tabandeh, RM Tehrani, M Sharifi, E Toopchi - 2024 - researchsquare.com
Melanoma is one of the variable nature and deadliest form of skin cancers and the mutations
play a major role in its development. It has faced many challenges in treatment and has led …

Network Pharmacology and Molecular Docking Analyses of the Mechanism of Action of Berberine in the Treatment of Melanoma.

Z He, A Huang, J Lv, J Zhou, W Lou… - Current Topics in …, 2024 - search.ebscohost.com
Melanoma is a cutaneum carcinoma caused by the malignant transformation of
melanocytes. This study aimed to predict potential targets of berberine in melanoma …

Assessment of Metabolic Imaging Biomarkers for MEK Inhibition Therapy Response in Melanoma

PK Gupta, S Orlovskiy, F Arias-Mendoza, DS Nelson… - 2024 - preprints.org
The MAPK signaling pathway with BRAF mutations has been shown to drive the
pathogenesis of 40-60% of melanomas. Inhibitors of this pathway's BRAF and MEK …

[HTML][HTML] Ruolo della metilazione del DNA nella regolazione di SLC22A17 nel melanoma cutaneo

A Lavoro - 2024 - tesidottorato.depositolegale.it
Cutaneous melanoma represents one of the deadliest forms of skin cancer due to its high
invasiveness and metastatic tendency. Despite recent advances in screening programs and …